Biotech beauty company Debut has secured $20 million in investment to enhance its AI-driven ingredient discovery platform and expand its formulation business in Asia.

The San Diego-based biotech start-up’s fundraising round was supported by Fine Structure Ventures, EDBI, Wealthberry, L’Oréal, GS Futures, Sandbox Industries and Material Impact, among others. To date, Debut has raised $85 million.

The latest fundraising round will be used to advance skin longevity innovation and scale its formulation business in the U.S. and Asia.

For ingredient discovery, it is focusing on the next-generation ingredients that target the 14 hallmarks of aging.

“Debut is laser-focused on staying at the forefront of skin care innovation and bringing cutting-edge biotech to every beauty brand with the h

See Full Page